Dyne Therapeutics cuts target price to $15 from $40
DYN•Oppenheimer cut its target price for Dyne Therapeutics to $15 from $40.
Related News
IHG signs first Garner hotel in Uzbekistan, with 100 rooms planned for 2027 opening
IHG•
Materialise maintains 2026 adjusted EBIT forecast at EUR 12 million–14 million
MTLS•
Nautilus Biotechnology target price raised to $4 from $3.5 by Roth MKM
NAUT•
Frontier Airlines delivers record third-quarter 2026 revenue of $1.4 billion, up 53% year over year
ULCC•
ConnectM appoints Leo Riera as lead independent director
CNTM•